ENST00000419536.1:n.246+14730G>C

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The ENST00000419536.1(AP4B1-AS1):n.246+14730G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: ENST00000419536.1 is not a MANE Select or MANE Plus Clinical transcript for AP4B1-AS1; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.813 (AC=123,632) in the gnomAD database across 152,128 control chromosomes, including 51,265 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.95. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars).

Frequency

Genomes: 𝑓 0.81 ( 51265 hom., cov: 32)

Consequence

AP4B1-AS1
ENST00000419536.1 intron

Scores

3

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.196

Publications

49 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000419536.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.95 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000419536.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

AP4B1-AS1 NR_037864.1
HGVSc / HGVSpn.246+14730G>C
Exon rankIntron 3 of 4
intron
Prot:
AP4B1-AS1 NR_125965.1
HGVSc / HGVSpn.415-25122G>C
Exon rankIntron 3 of 4
intron
Prot:

Ensembl Transcripts

AP4B1-AS1 ENST00000419536.1
TSL:2
HGVSc / HGVSpn.246+14730G>C
Exon rankIntron 3 of 4
intron
Prot:
AP4B1-AS1 ENST00000717022.1
HGVSc / HGVSpn.441-22414G>C
Exon rankIntron 3 of 5
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.812
AC:123506
Hom:51201
AN:152010
Cov:32
GnomAD4 genome
AF: 0.813
AC:123632
Hom:51265
AN:152128
Cov:32
TOPMed (Bravo)
AF: 0.813
AC:215257
Hom:89763
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.812
AC:19088
Hom:7869
AN:23494
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.818
AC:1915
Hom:790
AN:2342
ChinaMAP Phase 1
AF: 0.358
Denmark Genome
AF: 0.700
AC:210
AN:300
GenomeAsia100K
AF: 0.677
AC:2356
AN:3478
Korea4K (4,157 Koreans)
AF: 0.355
AC:2566
AN:7232
Qatari Genome
AF: 0.744
AC:131
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.411
AC:50395
Hom:10430
AN:122656
Turkish Variome
AF: 0.795
AC:1229
Hom:493
AN:1546
UK10K
AF: 0.792
AC:5986
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.377
AC:3381
Hom:649
AN:8960
Showing 14 sources

ClinVar

ClinVar submissions
Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Diabetes mellitus, insulin-dependent, susceptibility to (1)

Computational Scores

AlphaGenome AVI
Benign6.4
BayesDel_noAF
Benign-0.91
CADD
Benign3.8
DANN
Benign0.58
GPN-Star LLR
N/A5.0
GPN-Star score
N/A0.47
PhyloP100
Benign-0.20
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.